ETFs with TEVA as a Top 10 Holding*Sponsored by:
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|21.95%||iShares MSCI Israel Capped Investable Market Index Fund (EIS)||+1.85 (4.34%)|
|2.9%||iShares MSCI ACWI ex US Health Care Sector Index Fund (AXHE)||+9.75 (14.70%)|
|1.15%||BLDRS Europe 100 ADR Index Fund (ADRU)||+1.86 (9.02%)|
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Teva Pharmaceutical Industries Limited (“Teva”) is a fully-integrated global pharmaceutical company. Our business includes three primary areas: generic, specialty and over-the-counter (“OTC”) medicines. As the world’s largest generic company with an established specialty medicines portfolio, Teva is strategically positioned to benefit from the current changes in the global healthcare environment. Teva’s business strategy seeks to capitalize on the growing global need for medicines and evolving market, economic and legislative dynamics. These changes include aging populations, increased spending on pharmaceuticals in emerging market countries, economic pressures on governments and private payors to provide cost-effective healthcare solutions, global evolution in healthcare, legislative reforms, unmet patient needs, an increase in patient awareness and the growing importance of OTC medicines. ... More ...